NEOGENOMICS INC (NEO)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NEO
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NEO | Board Member and Chair of the Culture and Compensation Committee | 66 | ["40 years of global executive leadership experience","Led the growth and operations of several businesses","Experience in mergers and acquisitions","Retired president and CEO of Terumo BCT","Guided Terumo BCT through foreign ownership structures","Led multinational businesses and cross-cultural organizations","Transformed Terumo BCT to a global biomedical organization","Holds a BA in Political Science from Texas Tech University","Expertise in strategic planning, culture and talent development, succession planning, enterprise risk management, operations, compliance, and corporate governance","Strategy/Business Development / M&A","Risk Management","Public Policy / Regulatory Affairs"] | ["Audit and Finance Committee","Culture and Compensation Committee","Innovation, Pipeline & Technology Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MLAB | Director | 60 | ["significant experience in the medical products business","deep knowledge in growing and scaling a highly regulated global medical device business","strategic planning","innovation processes","product development","manufacturing","enterprise risk management","talent development","succession planning"] | [] | 2020 |